Physician profile
Christopher Buddendorff
NPI 1265465603
$1,043.39
in general payments reported to CMS, 2019-2025
10 companies · $111 in 2025
The $111 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $39.07 · 2021: $161 · 2022: $54.87 · 2023: $122 · 2024: $39.02 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $134.89 | 2019-2022 | |
| Genentech USA, INC. | $126.51 | 2019 | |
| Janssen Pharmaceuticals, INC | $125.70 | 2019-2021 | |
| Alkermes, INC. | $125.00 | 2019 | |
| Gilead Sciences, INC. | $124.73 | 2019 | |
| Glaxosmithkline, LLC. | $121.87 | 2021 | |
| Corium, LLC | $121.82 | 2023 | Azstarys |
| Sanofi-Aventis U.S. LLC | $110.95 | 2025 | |
| Merck Sharp & Dohme LLC | $39.02 | 2024 | Dificid |
| Astrazeneca Pharmaceuticals LP | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Buddendorff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.